Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer

This publication has 42 references indexed in Scilit:

• Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin
  Molecular Cell, 2005
• A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo‐fragments around budding foci
  Histopathology, 2005
• Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor)
  Oncogene, 2003
• RHAMM Is a Centrosomal Protein That Interacts with Dynein and Maintains Spindle Pole Stability
  Molecular Biology of the Cell, 2003
• Signaling Properties of Hyaluronan Receptors
  Journal of Biological Chemistry, 2002
• The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells
  The Journal of Pathology, 2001
• CD44 is the Principal Mediator of Hyaluronic-Acid-Induced Melanoma Cell Proliferation
  Journal of Investigative Dermatology, 2001
• Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers
  Oncogene, 1998
• Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation
  Cell, 1995
• Prognostic value of tumor “budding” in patients with colorectal cancer
  Diseases of the Colon & Rectum, 1993